Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis (vol 92, pg 1296, 2007)

被引：0
|
作者：
Delmas, Pierre D.
Vrijens, Bernard
Eastell, Richard
Roux, Christian
Pols, Huibert A. P.
Ringe, Johann D.
Grauer, Andreas
Cahall, David
Watts, Nelson B.
机构：
来源：
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM | 2007年 / 92卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：2285 / 2285
页数：1
相关论文
共 50 条
  • [1] Effect of monitoring bone turnover markers on persistence with risedronate treatment of postmenopausal osteoporosis
    Delmas, Pierre D.
    Vrijens, Bernard
    Eastell, Richard
    Roux, Christian
    Pols, Huibert A. P.
    Ringe, Johann D.
    Grauer, Andreas
    Cahall, David
    Watts, Nelson B.
    [J]. JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2007, 92 (04): : 1296 - 1304
  • [2] The role of bone turnover markers in monitoring treatment in postmenopausal osteoporosis
    Szulc, Pawel
    [J]. CLINICAL BIOCHEMISTRY, 2012, 45 (12) : 907 - 919
  • [3] DETERMINATION OF THE DIFFERENCES BETWEEN RALOXIFEN AND RISEDRONATE TREATMENT ON BONE TURNOVER MARKERS AND BONE MINERAL DENSITY IN POSTMENOPAUSAL OSTEOPOROSIS
    Yeter, A.
    Kavuncu, V.
    Evcik, D.
    Demirdal, U. S.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2009, 20 : 107 - 107
  • [4] Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Mengu Sarioglu
    Cigdem Tuzun
    Zeliha Unlu
    Canan Tikiz
    Fatma Taneli
    B. Sami. Uyanik
    [J]. Rheumatology International, 2006, 26 : 195 - 200
  • [5] Comparison of the effects of alendronate and risedronate on bone mineral density and bone turnover markers in postmenopausal osteoporosis
    Sarioglu, M
    Tuzun, C
    Unlu, Z
    Tikiz, C
    Taneli, F
    Uyanik, BS
    [J]. RHEUMATOLOGY INTERNATIONAL, 2006, 26 (03) : 195 - 200
  • [6] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Aysegul Atmaca
    Olcay Gedik
    [J]. Advances in Therapy, 2006, 23 : 842 - 853
  • [7] Effects of alendronate and risedronate on bone mineral density and bone turnover markers in late postmenopausal women with osteoporosis
    Atmaca, Aysegul
    Gedlik, Olcay
    [J]. ADVANCES IN THERAPY, 2006, 23 (06) : 842 - 853
  • [8] Osteoporosis treatment monitoring: Utility of bone turnover markers
    Bainbridge, PR
    Yap, TS
    Hannon, RA
    Price, A
    Catch, I
    Peel, NF
    Eastell, R
    [J]. OSTEOPOROSIS INTERNATIONAL, 2000, 11 : S61 - S61
  • [9] Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
    K.E. Naylor
    E.V. McCloskey
    R.M. Jacques
    N.F.A. Peel
    M.A. Paggiosi
    F. Gossiel
    J.S. Walsh
    R. Eastell
    [J]. Osteoporosis International, 2019, 30 : 917 - 922
  • [10] Clinical utility of bone turnover markers in monitoring the withdrawal of treatment with oral bisphosphonates in postmenopausal osteoporosis
    Naylor, K. E.
    Mccloskey, E., V
    Jacques, R. M.
    Peel, N. F. A.
    Paggiosi, M. A.
    Gossiel, F.
    Walsh, J. S.
    Eastell, R.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2019, 30 (04) : 917 - 922
12345